Phosphate and R2D2 Restrict the Substrate Specificity of Dicer-2, an ATP-Driven Ribonuclease
Cenik, Elif Sarinay ; Fukunaga, Ryuya ; Lu, Gang ; Dutcher, Robert ; Wang, Yeming ; Hall, Traci M. Tanaka ; Zamore, Phillip D.
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
RNA Helicases
Ribonuclease III
RNA, Small Interfering
MicroRNAs
RNA, Double-Stranded
Adenosine Triphosphate
Substrate Specificity
Dicer-1
Dicer-2
R2D2
ATP
helicase
phosphate
processivity
substrate specificity
Biochemistry, Biophysics, and Structural Biology
Pharmacology, Toxicology and Environmental Health
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Drosophila Dicer-2 generates small interfering RNAs (siRNAs) from long double-stranded RNA (dsRNA), whereas Dicer-1 produces microRNAs (miRNAs) from pre-miRNA. What makes the two Dicers specific for their biological substrates? We find that purified Dicer-2 can efficiently cleave pre-miRNA, but that inorganic phosphate and the Dicer-2 partner protein R2D2 inhibit pre-miRNA cleavage. Dicer-2 contains C-terminal RNase III domains that mediate RNA cleavage and an N-terminal helicase motif, whose function is unclear. We show that Dicer-2 is a dsRNA-stimulated ATPase that hydrolyzes ATP to ADP; ATP hydrolysis is required for Dicer-2 to process long dsRNA, but not pre-miRNA. Wild-type Dicer-2, but not a mutant defective in ATP hydrolysis, can generate siRNAs faster than it can dissociate from a long dsRNA substrate. We propose that the Dicer-2 helicase domain uses ATP to generate many siRNAs from a single molecule of dsRNA before dissociating from its substrate.
Source
Cenik et al., Phosphate and R2D2 Restrict the Substrate Specificity of Dicer-2, an ATP-Driven Ribonuclease, Molecular Cell (2011), doi:10.1016/j.molcel.2011.03.002
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
Permanent Link to this Item
PubMed ID
Other Identifiers
Notes
Co-author Elif Sarinay Cenik is a student in the Biochemistry & Molecular Pharmacology program in the Graduate School of Biomedical Sciences (GSBS) at UMass Medical School.